Autres langues Glenmark Life Sciences Limited Bombay S.E.

Actions

GLS

INE03Q201024

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:48 02/05/2024			Varia. 5j.	Varia. 1 janv.
841,2 ^INR	+1,46%		+1,68%	+28,02%

25/04	Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024
25/04	Glenmark Life Sciences Limited publie ses résultats pour le quatrième trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Glenmark Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04
Glenmark Life Sciences Limited Announces Resignation of Gita Nayyar as Non-Executive, Independent Director	22/04
Nirma Limited completed the acquisition of 75% stake in Glenmark Life Sciences Limited from Glenmark Pharmaceuticals Limited.	12/03
Glenmark Life Sciences Limited Announces Board Resignations, Effective March 6, 2024	06/03
Nirma Limited completed the acquisition of 0.000738% stake in Glenmark Life Sciences Limited.	29/02
Glenmark Pharmaceuticals Ltd. reports Consolidated Revenue of Rs. 29,096 Mn for Q3 FY 2023 24	15/02
India's Glenmark Pharma posts loss for Q3 as remediation cost weighs	14/02
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO	23/01
Glenmark Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	23/01
Paracetamol maker Granules India posts marginal rise in Q3 profit	23/01
Glenmark Life Signs Master Supply Agreement with Japanese Drugmaker for Urinary Anti-Spasmodic API	19/01
Glenmark Life Sciences Announces Another CDMO Deal	19/01
India's Glenmark Pharma posts Q2 loss on exceptional legal costs	10/11
Paracetamol maker Granules India's Q2 revenue rises on higher N.America demand	09/11
India's Glenmark Life Sciences posts Q2 profit rise on API boost	20/10/23
Glenmark Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/10/23
Glenmark Life Sciences Limited Declares Interim Equity Dividend for the Financial Year 2023-24, Payable on or After October 23, 2023	09/10/23
Indian paracetamol maker Valiant Laboratories lists at 16% premium	06/10/23
Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable	04/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Glenmark Life Sciences Limited Bombay S.E.

Actions

GLS

INE03Q201024

Autres langues

Filtres